Skip to Content

Pfizer Inc

PFE: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$64.00FkhpRzyxmwvk

Pfizer's Diverse Portfolio of Drugs and Vaccines Supports Steady Cash Flows

Business Strategy and Outlook

Pfizer's foundation remains solid, based on strong cash flows generated from a basket of diverse drugs. The company's large size confers significant competitive advantages in developing new drugs. This unmatched heft, combined with a broad portfolio of patent-protected drugs, has helped Pfizer build a wide economic moat around its business.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of PFE so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center